Becton Dickinson (BDX)EVP and Chief ISC Officer sold ~$200K

~$200K

Approx. value · 1,166 sh @ $171.19

4,575

Holds after · shares reported

Traded

Jun 2, 2025

Filed

Jun 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 5, 2025CongressDisclosed sale of BDX — reported range $15,001 - $50,000
2. Apr 8, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
3. Apr 9, 2025InsiderOfficer sold ~$94K of BDX shares in the open market
4. May 13, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
5. May 15, 2025CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
6. Jun 2, 2025 · this disclosureInsiderOfficer sold ~$200K of BDX shares in the open market

What came next

1. Jun 17, 2025Congress · 1 personMembers of Congress: 2 purchases
2. Jun 24, 2025CongressDisclosed sale of BDX — reported range $1,001 - $15,000
3. Jul 18, 2025Insider · 1 personInsiders: 2 sales (~$214K)
4. Aug 8, 2025InsiderDirector sold ~$166K of BDX shares in the open market
5. Aug 11, 2025InsiderDirector purchased ~$1.01M of BDX shares in the open market
6. Aug 21, 2025FDARecall: Venclose digiRF Generators, Model VCRFG1, with software 3.35 designed to identify internal wiring anomalies in the Venclose EVSRF Ablation Catheter prior to us…
7. Aug 22, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
8. Sep 5, 2025FDAFDA device clearance: Vaccess™ CT Low-Profile Power-Injectable Implantable Port; Vaccess™ CT Power-Injectable Implantable Port; PowerPort™ duo M.R.I. ™ Implantable Port
9. Sep 10, 2025InsiderDirector sold ~$172K of BDX shares in the open market
10. Sep 11, 2025FDARecall: BD Alaris Pump Infusion Sets for the following reference numbers: C24101E, Amber Tubing, 15 Micron Filter, 0.2 Micron Filter, SmartSite Y-Site 10015414, 180 Mi…
11. Sep 12, 2025FDAFDA device clearance: BD PhaSeal™ Optima Connecting Set (C83-O); BD PhaSeal™ Optima Spike Set (C180-O)
12. Sep 16, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
13. Sep 23, 2025FDARecall: BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/G, Catalog Number: 441002. 2. COMPUTER OPTIPLEX EPIC…
14. Sep 23, 2025FDARecall: BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 System, Catalog Numbers: 445570, 445702. 2. INSTRUMENT BACTEC 9120 UNREPAIRED, Catalog…
15. Sep 23, 2025FDARecall: BD Veritor Connect Software, labeled as the following: 1. Veritor (NUC), Catalog Number: 444881. Transfers in vitro diagnostic results data on the BD Veritor P…
16. Sep 23, 2025FDARecall: BD BACTEC Blood Culture System, labeled as the following: 1. BD BACTEC FX, Instrument Top, Packaged, Catalog Number: 44138509. 2. Instrument Top Remanufactured…
17. Sep 23, 2025FDARecall: BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1. BD MAX System, BD MAX Instrument, Catalog Numbers: 44191609, 441927.
18. Sep 23, 2025FDARecall: BD Phoenix M50 Instrument, labeled as the following: 1. BD Phoenix M50 Automated Microbiology System, Catalog Numbers: 443624, 44362409.
19. Sep 26, 2025InsiderOfficer sold ~$10K of BDX shares in the open market
20. Sep 30, 2025FDARecall: BD Pyxis Pro MedStation Main, REF: 1155-00

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by David Shan, EVP and Chief ISC Officer

• SEC Form 4 at Becton Dickinson (BDX)Jan 22, 2025
• SEC Form 4 at Becton Dickinson (BDX)Dec 6, 2024

The full history of David Shan, EVP and Chief ISC Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Becton Dickinson

• SEC Form 4Sep 30, 2026
• SEC Form 144Sep 28, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 18, 2026
• SEC Form 4Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BDX page.